on 21 May 2024
Last Applicant/ Owned by
435 DEVON PARK DRIVE, SUITE 400
WAYNE
PA
19087
Serial Number
97296483 filed on 04th Mar 2022
Registration Number
7392426 registered on 21st May 2024
Correspondent Address
Allison Z. Gifford
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
Research and development for others of chemicals, pharmaceuticals, and active pharmaceutical ingredients Chemical compounds for use in the manufacture of pharmaceuticals; chemicals for use as active pharmaceutical ingredients for treating cardiovascular diseases, cancers, metabolic disorders, respiratory diseases, opiate dependence, neurological diseases, ophthalmological diseases and conditions, Read More
Research and development for others of chemicals, pharmaceuticals, and active pharmaceutical ingredients
04th Mar 2022
01st Jun 2022
Chemical compounds for use in the manufacture of pharmaceuticals; chemicals for use as active pharmaceutical ingredients for treating cardiovascular diseases, cancers, metabolic disorders, respiratory diseases, opiate dependence, neurological diseases, ophthalmological diseases and conditions, and for the relief of pain; chemical preparations used to denature other substrates by rendering them unsuitable for human consumption
04th Mar 2022
01st Jun 2022
Custom synthesis in the nature of custom manufacturing of chemical compounds for use in the manufacture of pharmaceuticals and active pharmaceutical ingredients
04th Mar 2022
01st Jun 2022
No 97296483
No Service Mark
No 187311-5001
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
21st May 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
21st May 2024 | REGISTERED-PRINCIPAL REGISTER |
16th Apr 2024 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
15th Apr 2024 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
29th Mar 2024 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
29th Mar 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
29th Mar 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
25th Jan 2024 | NOTIFICATION OF FINAL REFUSAL EMAILED |
25th Jan 2024 | FINAL REFUSAL E-MAILED |
25th Jan 2024 | SU - FINAL REFUSAL - WRITTEN |